Principal investigator of the National Lung Screening Trial, which first proved CT screening saves lives.
Denise Aberle was national principal investigator of the ACRIN arm of the National Lung Screening Trial, whose 2011 result of a 20% reduction in lung cancer mortality with low-dose CT led to the first lung screening recommendations and Medicare coverage in the United States. She continues to work on quantitative imaging and AI for nodule assessment.
Shares NLST & NELSON (low-dose CT screening), NLST: yearly low-dose CT scans cut lung cancer deaths in heavy smokers, CT (computed tomography), Non-small-cell lung cancer and the tags screening, lung.
Shares NLST & NELSON (low-dose CT screening), Non-small-cell lung cancer and the tags screening, lung.
Shares AI in radiology, CT (computed tomography), Non-small-cell lung cancer and the tag lung.
Shares AI in radiology, CT (computed tomography) and the tag radiology.
Shares AI in radiology, CT (computed tomography) and the tag radiology.
Shares Non-small-cell lung cancer and the tags screening, lung.
Shares Non-small-cell lung cancer and the tags screening, lung.
Shares Non-small-cell lung cancer and the tags screening, lung.